Generic filters

Chronic Inflammatory Bowel Disease: Endoscopic Scores

Thomas Klag and Martin Goetz , Tübingen


Chronic inflammatory bowel disease (IBD) with its two forms, Crohn’s Disease (CD) and Ulcerative Colitis (UC), can be classified by various endoscopic scores with regards to endoluminal inflammatory activity of the diseases. Therefore, endoscopy is a central part of the diagnostic work-up for treatment decisions and guidance of therapy (e.g. by assessment of treatment response) (1). In CD and UC, different scores have been established. The aim of using these endoscopic scores is to achieve some degree of objectivity and comparability. Certainly, individual assessment of inflammatory features – mucosal reddening, for example – is dependent on subjective evaluation. The scores nevertheless are important in the setting of studies to provide a standardized basis for assessment (2). Classification according to pattern and localization of involvement is not the topic of this report – for that, see terminology projects such as the most recent one by the German society DGVS (3).

Endoscopic Scores – Crohn’s Disease

The so-called “Crohn’s Disease Endoscopic Index of Severity” (CDEIS) was the first endoscopic activity index for CD, but it was less suitable for everyday practice due to its complexity. Therefore, an easier to use version was developed: the “Simple Endoscopic Score for Crohn’s Disease” (SES-CD) (4). This score is based on the evaluation of five defined bowel segments (rectum, sigma + descending colon, transverse colon, ascending colon, and terminal ileum), and in these segments the presence and size of ulcerations and the extent of the inflammatory area and stenosis are assessed, then classified in severity as a score of 0–3. The scores for each individual segment are added together as a sum score (see Table 1) (4).

Table 1: “Simple Endoscopic Score for Crohn’s Disease” (SES-CD) (4).

Severity 0 1 2 3
Ulcerations none aphtoid <0,5cm 0,5 – 2cm >2cm
Ulcerated surface none <10% 10 – 30% >30%
Inflamed surface none <50% 50 – 75% >75%
Stenosis none single,
not passable

Examples are shown in Figures 1a–d.

Abb. 1: SES-CD:

  • a) SES-CD-Ulceration 1: aphthous lesion term ileum
  • b) SES-CD-Ulceration 3: Ulceration > 2 cm term. ileum
  • c) SES-CD-inflammatory surface in a large area but without ulcerations
  • d) SES-CD-Stenosis 3: no endoscopic passage possible

The so-called “Rutgeerts Score” was developed to classify postoperative changes after resection (ileocecal resection). It includes an assessment of inflammatory lesions in the anastomotic area (ulcerated/aphthoid), which are predictive for the further clinical course (increased likelihood of disease recurrence) (5,6). Table 2 provides an overview of the different grades of this score.

Table 2: “Rutgeerts Score” for postoperative assessment (likelihood of relapse) in CD (5,6).

Severity Endoscopic findings
I0 no lesions
¡1 <5 aphthous lesions in the neoterminal ileum
¡2 >5 anastomotic lesions with passable stenosis (skip lesions); or lesions in the area of the anastomosis
¡3 diffuse ileitis
¡4 diffuse ileitis with deep ulcerations and/or Stenosis

Examples are shown in Figures 2a–d.

Fig. 2: Rutgeerts Score.

  • a) i1: <5 aphthous lesions in the neoterminal ileum
  • b) i2: anastomotic lesions with passable stenosis
  • c) i3: diffuse ileitis
  • d) i4: diffuse ileitis with deep ulcerations

Endoscopic Scores – Ulcerative Colitis

Several scores are available for endoscopic assessment of disease activity in UC. The most relevant scores, “Ulcerative Colitis Endoscopic Index of Severity” (UCEIS), Baron Score and Mayo Score, are detailed in the following.

For studies in particular, the UCEIS is the score that has been validated most and has reached the best correlation with clinical symptoms and could be used for further disease prediction. Vascular pattern, bleeding and erosions/ulcerations are scored (Table 3) (7); however, the unclear differentiation between erosion and superficial ulceration has been criticized with the UCEIS score.

Table 3: “Ulcerative Colitis Endoscopic Index of Severity” (UCEIS) (7).

(the most serious change is evaluated)
(Likert Scale)
Vessels 1 = normal
2 = partial loss
3 = total loss
Bleeding 1 = none
2 = mucosal
3 = luminal bleeding (mild)
4 = luminal bleeding (severe)
Erosions/ulcerations 1 = none
2 = erosion
3 = superficial ulcerations
4 = deep ulcerations

Examples are shown in Figures 3a–e.

Fig. 3: UCEIS.

  • a) partial loss of vessels
  • b) luminal bleeding, mild
  • c) luminal bleeding, severe
  • d) superficial ulcerations
  • e) deep ulcerations

The so-called Baron Score classifies mucosal changes into 3 grades: 0=normal mucosa; 1=inflammatory changes without bleeding; 2=bleeding with minimal endoscopic manipulation; 3=spontaneous bleeding (8). Remission is defined as Baron Score </= 1.

The so-called Mayo Score is a hybrid between clinical and endoscopic variables; stool frequency, bleeding, inflammatory activity on sigmoidoscopy, overall physician assessment and daily activities of the patient are assessed (Table 4) (9). In studies, a decrease of the score by 3 or more is usually taken as therapeutic success. For the assessment of endoscopic mucosal response, the endoscopic subscore is most often used, and mucosal healing is diagnosed with an endoscopic subscore of 0 or 1 (but subscore 1 can mean clearly visible remaining inflammatory activity). It must also to be mentioned that the Mayo score was developed long before the advent of HD endoscopes, which are standard nowadays.

Table 4: “Mayo Score” (9)

0 1 2 3
Stool frequency
(above average)
0 1 – 2 3 – 4 >5
Bleeding none mild moderate severe
Sigmoidoscopy inactive mild moderate severe
Overall physician assessment normal mild moderate severe
Daily activities normal slightly restricted  significantly restricted massively restricted

Examples are shown in Figures 4a–d.

Fig. 4: Endoscopic Subscore, Mayo Score.

  • a) inactive
  • b) mild
  • c) moderate
  • d) severe

All the scores mentioned above are useful for the assessment of acute inflammation. In clinical remission however, the endoscopic assessment had become increasingly important to precisely diagnose residual endoscopic-histologic inflammatory activity or mucosal healing. At least in UC, the so-called PICaSSO Score (Paddington International virtual Chromoendoscopy ScOre) has been validated (10). This score includes two categories: mucosal and vascular changes (Table 5). These can be subclassified into subcategories according to the extent of the involved mucosal area.

Table 5: “PICaSSO-Score” (10).

Mucosal changes none Microerosions/
Erosions <
Erosions >
Vascular changes Non-dilated vessels/td> Dilated vessels Intramucosal bleeding Luminal bleeding

Up to now, there are well-known changes in IBD that are not included in the above mentioned classification systems. These changes are not really related to inflammation, but rather to chronic mucosal changes in conjunction with functional impairment (e.g. extensive scarring) or with difficulties in surveillance (multiple pseudopolyps, villous-hypertrophic mucosal changes).

Examples are shown in Figures 5a–d.

Fig. 5: Not included in scores:

  • a) villous colonic changes
  • b) pseudopolyps
  • c) extensive colonic atrophy
  • d) Colon with multiple visible scars


  1. Goetz M. Endoscopic Surveillance in Inflammatory Bowel Disease. Visc Med 2018;34:66–71.
  2. Wehkamp J, Götz M, Herrlinger K, Steurer W, Stange EF. Inflammatory Bowel Disease. Dtsch Arztebl Int 2016; 113:72-82.
  3. Alexander Meining, Werner Schmidbaur, Brigitte Schumacher, Thomas Toermer, Martin Keuchel, Peter Baltes, Ulrike Denzer, Martin Götz, Ralf Jakobs, Jochen Klaus, Gero Moog, Ulrich Rosien, Stefan von Delius, Till Wehrmann, Markus M. Lerch, Frank Lammert. Neufassung der Terminologie in der gastroenterologischen Endoskopie – Ergebnis eines Konsensusprojekts der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselerkrankungen. Z Gastro 2017, 55:1233-1240
  4. Daperno M, D’Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc 2004; 60:505-512.
  5. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Koremans R, Hiele M. Predictability of the postoperative course of Crohn’s disease. Gastroenterology 1990; 99: 956–563.
  6. Sostegni R, Daperno M, Scaglione N, Lavagna A, Rocca R, Pera A. Review article: Crohn’s disease: monitoring disease activity. Aliment Pharmacol Ther 2003; 17:11-17.
  7. Travis SP, Schnell D, Krzeski P, et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 2012; 61:535-542.
  8. Baron J, Connell A, Lennard-Jones J. Variation between observers in describing mucosal appearances in proctocolitis. BMJ 1964; 1:89.
  9. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderate active ulcerative colitis. A randomized study. N Engl J Med 1987; 26:1625-1629.
  10. Iacucci M, Daperno M, Lazarev M, Arsenascu R, Tontini GE, Akinola O, Gui XS, Villanacci V, Goetz M, Lowerison M, Lethebe BC, Vecchi M, Neumann H, Ghosh S, Bisschops R, Kiesslich R. Development and reliability of the new endoscopic virtual chromoendoscopy score: the PICaSSO (Paddington International Virtual Chromoendoscopy ScOre) in ulcerative colitis. Gastrointest Endosc 2017, 86(6):1118-1127.

Related Posts

Scroll to Top